AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05523466 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Acupuncture Active
Description: Immediately after the placement of the Polar V800, an instrument for analyzing heart rate variability, the placing of needles at the points carefully selected for this research begins. The needling will proceed for the Active acupuncture using specific Traditional Chinese Acupuncture points: E36, BP6, F3, IG4, for 20 minutes.
Study NCT05523466 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Acupuncture Sham
Description: Immediately after the placement of the Polar V800, an instrument for analyzing heart rate variability, the placing of needles at the points carefully selected for this research begins. The needling will proceed for the Sham acupuncture using sham points (points not recognized as Acupuncture points), with the duration of 20 minutes
Study NCT06019806 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: POSTURAL CORRECTION four exercises
Description: The program will involve four exercises, including two strengthening exercises and two stretching exercises.~1. Chin tuck (deep cervical flexor)~2. Strengthening shoulder retractors~3. Sternocleidomastoid muscle stretch~4. Pectoralis stretch Participants will be instructed to perform three sets of 12 repetitions for the strengthening exercises, with a 30-second rest period allotted between each set. For the stretching exercises, participants will be instructed to hold each stretch for 30 seconds, with a 30-second rest period allotted between each exercise The experimental group will also receive postural Correction education
Study NCT06019806 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: postural Correction education with a manuscript
Description: The control group would receive postural Correction education and they would be provided with a manuscript. They would be then guided to follow these guidelines as a home plan for four weeks. At the end of the Fourth week, they would be assessed.
Study NCT05551052 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Next-Gen CRC Screening Test
Description: The Next-Gen CRC Screening Test is a blood-based screening test for detection of CRC.
Study NCT04971252 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Hematologic tests for patients with diabetes mellitus and chronic kidney disease
Description: Study basic coagulation profile and platelet indices among diabetic patients with chronic kidney disease
Study NCT05285306 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PEACE Program
Description: This pilot will consist of 3 individual telemedicine sessions to teach cognitive behavioral coping skills and provide education related to gynecologic cancer surveillance and psychological distress.
Study NCT05117203 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: WB-EMS (Whole body electrostimulation)
Description: Application of physical exercise and electrical stimulation on the abdominal muscles through the WB-EMS during 20 minutes training session with specific exercise (CORE)
Study NCT05117203 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EMS
Description: Application of physical exercise and electrical stimulation on the abdominal muscles through the EMS during 20 minutes training session with specific exercise (CORE)
Study NCT05117203 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: WB-EMS off
Description: Application of physical exercise without electrical stimulation on the abdominal muscles through the WB-EMS off during a 20 minutes training session with specific exercise (CORE).
Study NCT05787106 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cyberball task
Description: The game consists of ball throws between animated characters lasting about 50 throws. In the rejection condition, after 2 or 3 throws, the participant no longer receives the ball (no more passes). In the control conditions (all included), the participant receives the ball as often as the others.
Study NCT05583032 — intervention group
Intervention type: DEVICE
Intervention: ScanNav Anatomy PNB
Description: AI-powered device that highlights anatomy of interest during ultrasound scans.
Study NCT03943849 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Particulate bone graft
Description: Creos allo.gain allogenic bone particulate mineralized cortical bone will be hydrated and placed in the extraction socket.
Study NCT03943849 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Particulate bone graft
Description: Creos allo.gain allogenic bone particulate mineralized cortical bone will be hydrated and placed in the extraction socket.
Study NCT03943849 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Autogenous dental pulp tissue
Description: Dental pulp will be isolated from teeth extracted for non-periodontal reasons chairside, mixed with hydrated particulate bone graft, and then placed in the extraction socket.
Study NCT03943849 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Resorbable collagen membrane
Description: After placement of particulate bone graft or particulate bone graft plus autogenous dental pulp tissue, socket will be covered by a resorbable collagen membrane and sutured.
Study NCT03943849 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Resorbable collagen membrane
Description: After placement of particulate bone graft or particulate bone graft plus autogenous dental pulp tissue, socket will be covered by a resorbable collagen membrane and sutured.
Study NCT03943849 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Suture
Description: Resorbable or non-resorbable suture material
Study NCT04717687 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Irreversible electroporation
Description: Device: NanoKnife The aim of the treatment is to surround the tumour with two to six needles and to deliver a very high voltage current (3000 volts in 70 to 80 microseconds pulses) by a generator synchronized with an electrocardiogram.
Study NCT05963113 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Pharyngeal Swallowing Exercises
Description: 12-weeks of proactive pharyngeal swallowing exercises conducted 5 times per week. The exercise program will include the following four exercises: effortful saliva swallows, tongue-hold swallows, effortful pitch glides and posterior lingual resistance. Each exercise set will include 10 repetitions of each exercise (40 reps per set). The number of sets will be gradually increased as tolerance builds.
Study NCT05963113 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pharyngeal Swallowing Exercises
Description: 12-weeks of proactive pharyngeal swallowing exercises conducted 5 times per week. The exercise program will include the following four exercises: effortful saliva swallows, tongue-hold swallows, effortful pitch glides and posterior lingual resistance. Each exercise set will include 10 repetitions of each exercise (40 reps per set). The number of sets will be gradually increased as tolerance builds.
Study NCT05553886 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: To evaluate whether the efficacy of the study drug is noninferior to that of the positive control drug
Description: To evaluate whether the efficacy of the study drug is noninferior to that of the positive control drug
Study NCT05553886 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: To evaluate whether the efficacy of the study drug is noninferior to that of the positive control drug
Description: To evaluate whether the efficacy of the study drug is noninferior to that of the positive control drug
Study NCT04422951 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Wise interventions -- values self-affirmation and growth mindset -- plus usual care behavioral treatment
Description: Addition of two wise wise social psychological interventions-growth mindset and self-affirmation-to a 6-month usual care behavioral intervention for weight control in children with obesity
Study NCT04422951 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Education plus usual care behavioral treatment
Description: 6-month health education plus usual care behavioral intervention for weight control in children with obesity
Study NCT05577351 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: RapidPulseTM Aspiration System
Description: The RapidPulseTM Aspiration System paired with a single-use, disposable tubing set specific for use with the RapidPulseTM Aspiration System
Study NCT04781946 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Endoscopic pneumatic balloon dilation
Description: Using endoscopy, pneumatic balloon dilation may be used to treat stenosis of the gastric sleeve.
Study NCT04781946 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Gastric peroral endoscopic myotomy (G-POEM)
Description: Gastric per-oral endoscopic myotomy (G-POEM) is a recent innovation offering a minimally invasive endoscopic approach. G-POEM allows for the creation of a tunnel and subsequent myotomy from the gastric cardia to the gastric pylorus.
Study NCT04781946 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB)
Description: The Roux-en-Y gastric bypass is a type of weight-loss surgery that involves creating a small pouch from the stomach and connecting the newly created pouch directly to the small intestine.
Study NCT05963113 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Protein Supplementation
Description: 12-week supply of the commercially-available Premier Protein Clear ® High Protein (20 grams of protein and 90 calories per 16.9 oz. drink). Participants will be asked to consume one drink per day for the 12-week intervention period.
Study NCT05963113 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: MRI
Description: Participants will be scanned using a 3T MRI scanner and a 16-channel phased array neck coil.
Study NCT05963113 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MRI
Description: Participants will be scanned using a 3T MRI scanner and a 16-channel phased array neck coil.
Study NCT05645445 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: virtual reality
Description: patients who include intervention gruop during the ESWL process, patients will be shown videos with virtual reality glasses, which include nature and landscapes, giving people a feeling of comfort and peace, and making them feel like they are inside.
Study NCT03943849 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Suture
Description: Resorbable or non-resorbable suture material
Study NCT06500195 — intervention group
Intervention type: PROCEDURE
Intervention: implantation of the hybrid instrumentation system
Description: Surgery corrections were performed using the hybrid instrumentation system (screws and bands).
Study NCT04804202 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Bicycling with and without virtual reality
Description: In one session: Exercise intensity and enjoyment are measured while participants bicycle in a virtual compared to non-virtual environment. Cycling takes places in two modes continous and interval. In a second session exercise intensity and enjoyment are compared during bicycling with virtual reality presented in two different ways.
Study NCT04852809 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: This is an observational study
Study NCT05994690 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard Intervention Rc
Description: 3 consolidation courses (HAM + HA3E + FLA)
Study NCT05994690 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Investigational Intervention Rc
Description: 2 consolidation courses (HAM + FLA)
Study NCT05994690 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard Intervention Ri
Description: No addition of GO to first induction course
Study NCT05994690 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Investigational Intervention Ri
Description: Addition of GO to first induction course
Study NCT05771948 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: CCoat
Description: CCoat is a new intra-articular (IA) injectable joint lubricant for patients suffering from joint pain developed by Liposphere LTD. CCoat is a liposomal boundary lubricant which coats the cartilage surface and protects it from further damage and degradation.
Study NCT05771948 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CCoat
Description: CCoat is a new intra-articular (IA) injectable joint lubricant for patients suffering from joint pain developed by Liposphere LTD. CCoat is a liposomal boundary lubricant which coats the cartilage surface and protects it from further damage and degradation.
Study NCT05635474 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Bacillus Coagulans
Description: Bacillus coagulans is a Gram-positive bacterium belonging to the genus Bacillus and does not exist in the intestinal microbiota, because it has the characteristics of spore production and lactobacillus lactic acid production, and has the ability to maintain the health of intestinal bacteria, acid and alkali resistance, With the advantages of high temperature resistance and high stability, it is currently one of the commonly used probiotic strains.
Study NCT05635474 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The placebo was also administered in the form of capsules consisting of maltodextrin, silicon dioxide, and magnesium stearate.
Study NCT05678452 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: HOLEP for treating BPH
Description: HoLEP will be performed using 100W Versapulse, Luminis Inc., with 2J/25Hz for LP-HoLEP and 2J/50Hz for HP-HoLEP.
Study NCT05928416 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Saliva sample
Description: During the inclusion visit :~* a neurological examination is taken~* a saliva sample is taken
Study NCT05928416 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Saliva sample
Description: During the inclusion visit :~* a saliva sample is taken
Study NCT06253806 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Stellate Ganglion Block
Description: The stellate ganglion will be identified using ultrasound guidance, and after negative aspiration, 6-8 mL of 1% mepivacaine will be injected near the stellate ganglion.
Study NCT06253806 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Sham Injection
Description: The stellate ganglion will be identified using ultrasound guidance, and after negative aspiration, 6-8 mL of 0.9% saline will be injected near the stellate ganglion.
Study NCT04883515 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Oral glutamine supplementation
Description: patient will receive oral glutamine supplementation 10 g Ter In Die during 8 weeks
Study NCT06141343 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Intervention: Veillonella atypica FB0054
Description: Veillonella contains Veillonella atypica FB0054 as the active ingredient with microcrystalline cellulose and hypromellose as excipients. The two doses are 15 billion cfu (high dose) and 7.5 billion cfu (low dose). Placebo capsules contain microcrystalline cellulose and hypromellose. Both Veillonella and placebo are encapsulated in acid-resistant capsules to improve delivery to the large intestine, which participants will take orally at home on a daily basis for four weeks.
Study NCT06141343 — intervention group
Intervention type: OTHER
Intervention: Placebo
Description: Placebo will be given as the non-active study control
Study NCT05511311 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Resistance Training
Description: Resistance training developed by the researcher (SCR-RSCM) for 12 weeks
Study NCT05511311 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard Therapy
Description: Standard therapy for 12 weeks
Study NCT04883515 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Oral protein powder supplementation
Description: patient will receive oral protein powder supplementation10 g Ter In Die during 8 weeks
Study NCT04883515 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Insulin-resistance evaluation
Description: Homeostasic model assessment of insulin resistance test will be performed at baseline, Week 8 and Week 16
Study NCT04883515 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Insulin-resistance evaluation
Description: Homeostasic model assessment of insulin resistance test will be performed at baseline, Week 8 and Week 16
Study NCT04883515 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Functional intestinal disorders evaluation
Description: Functional intestinal disorders will be measured by the IBS severity score and feces consistency by Bristol scale at baseline, Week 8 and Week 16
Study NCT04883515 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Functional intestinal disorders evaluation
Description: Functional intestinal disorders will be measured by the IBS severity score and feces consistency by Bristol scale at baseline, Week 8 and Week 16
Study NCT04715867 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Rabix-VC
Description: Rabix-VC will be locally manufactured by Incepta Vaccine Ltd
Study NCT04715867 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rabix-VC
Description: Rabix-VC will be locally manufactured by Incepta Vaccine Ltd
Study NCT06173726 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BST02 Injection
Description: The TIL used for tumor tissue surgical sampling of qualified subjects was used to prepare BST02 injection, and the subjects who successfully received the surgical sampling were considered to be enrolled.~In the study process, cell transfusions were recorded as day 0 of the study. On the 3rd day (D-3) before infusion of BST02 injection, it is necessary to receive eluvial pretreatment. Considering that this product is unmodified autologous T lymphocytes, previous studies have shown that low-intensity cyclophosphamide can stimulate their proliferation in vivo. Therefore, the cyclophosphamide (Cy) single-drug regimen is recommended: Cy 250mg\~1.5g/m2, a single intravenous infusion
Study NCT05326685 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: video with korotkoff sounds
Description: The State-Trait Anxiety Inventory short version (STAIS-5, STAIT-5) and the student introduction form were applied at the beginning of the study. Then Intervention participants were shown and listened visual video with korotkoff sounds before blood presssure measurement. Afterwards, blood pressure was measured to the students 3 times and 3 measurements were recorded. After the application about 2 hours later, the students State Anxiety Inventory short version (STAIS-5) form was filled again by students.
Study NCT04361617 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Daily consumption of tree nuts and extra virgin olive oil
Description: All participants will receive a 4-week supply of extra virgin olive oil and tree nuts, including unsalted English walnuts, almonds or pistachios (approximately 3-day supply of each type). Participants will be asked to include in their normal diets these products and will be provided recipes and other information that will allow them to replace other foods with the nuts and oil. We will ask participants to consume one ounce of tree nuts per day and two tablespoons of EVOO per day by incorporating these foods into their diet.
Study NCT05281081 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: intraperitoneal levobupivacaine and morphine
Description: istillation of the peritoneum with levobupivacaine mixture with morphine
Study NCT05281081 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: intraperitoneal levobupivacaine and morphine
Description: istillation of the peritoneum with levobupivacaine mixture with morphine
Study NCT06418347 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alpha lipoic acid
Description: Alpha-lipoic acid (ALA), also known as 1,2-dithiolane-3-pentanoic acid or thioctic acid, is found in the mitochondria. It acts as an enzymatic cofactor for various enzymes in the Kreb's cycle. ALA has many beneficial properties making it a potential candidate for various clinical disorders. It is considered the universal or ideal antioxidant as it is both water-soluble and fat-soluble facilitating its passage across membran. ALA has direct as well as indirect anti-inflammatory effects. Being a potent antioxidant leads to a reduction in oxidative stress which in turn reduces inflammation, meaning ALA indirectly has anti-inflammatory effects. To add to ALA's benefits, it has anti-inflammatory properties that are independent of its antioxidant effects.
Study NCT06418347 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Letrozole
Description: Letrozole is an aromatase inhibitor that controls the conversion of androgen to estrogen and increases ovarian androgens. The administration of letrozole in the follicular phase removes the effect of negative estrogen feedback on the pituitary and hypothalamus, thus increasing the gonadotropins\]. When Letrozole blocks estrogen production, it encourages the body to produce more follicle-stimulating hormone (FSH).The additional FSH stimulates egg development and increases the likelihood of ovulation. Kar, S. Found that letrozole has excellent pregnancy rates compared to clomiphene citrate, Letrozole should be considered at par with clomiphene citrate as first-line drug for ovulation induction in infertile PCOS women.